Cointime

Solexa

company

About

Solexa develops a genome analysis system for genome resequencing, gene expression analysis and small RNA analysis.

  • 101 - 250

Highlights

Total Funding Amount
$75M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$75M
Industries
Biotechnology,Genetics,Medical,Medical Device
Founded date
Jan 1, 1998
Number Of Employee
101 - 250
Operating Status
Active

Solexa engages in developing and commercializing genetic analysis technologies primarily in the United States and the United Kingdom. The company is developing and preparing Solexa Genome Analysis System, which performs DNA sequencing based on its proprietary reversible terminator Sequencing-by-Synthesis, chemistry, and Clonal Single Molecule Array technology. Its platform is designed to support a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$75M
Solexa has raised a total of $75M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2006 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2006 Post-IPO Equity $75M 1 Azimuth Opportunity — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Solexa is funded by 1 investors. Azimuth Opportunity are the most recent investors.
Investor Name Lead Investor Funding Round
Azimuth Opportunity Yes Post-IPO Equity
Cointime
Содержание
компания